Quarterly 13F snapshot: US-listed longs only, no performance figures — 13F data cannot support them.
Reported portfolio value by quarter (37 quarters reported)
$91.2M in Q4 2015 → $20.5M now. Hover for any quarter.
As reported for the quarter ended December 31, 2024. Activity is the change in share count since the prior quarter's filing.
| Holding | % of portfolio | Activity | Shares | Value |
|---|---|---|---|---|
| Inseego Corp | 100.0% | Added 54% | 2,001,050 | $20.5M |
What changed each quarter, from the filings' own share counts. Largest moves first; most recent 8 quarters.
quarter ended December 31, 2024 · filed February 14, 2025
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Inseego Corp | Exited | −24,456,000 | −$19.9M | — |
| Inseego Corp | Added | +697,736 | +$7.16M | 100.0% |
quarter ended September 30, 2024 · filed November 14, 2024
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Inseego Corp | New | +1,303,314 | +$21.3M | 51.6% |
| Inseego Corp | Exited | −1,303,314 | −$13.9M | — |
quarter ended June 30, 2024 · filed August 14, 2024
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Inseego Corp | Trimmed | −1 | −$11 | 54.1% |
quarter ended March 31, 2024 · filed May 15, 2024
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Inseego Corp | Trimmed | −11,729,834 | −$32.8M | 27.7% |
quarter ended December 31, 2023 · filed February 14, 2024
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Mirati Therapeutics Inc | Exited | −3,135,966 | −$137M | — |
| Inseego Corp | Trimmed | −7,614,830 | −$1.68M | 22.1% |
| Tango Therapeutics Inc. | Exited | −26,961 | −$304K | — |
quarter ended September 30, 2023 · filed November 14, 2023
No position changes this quarter.
quarter ended June 30, 2023 · filed August 14, 2023
No position changes this quarter.
quarter ended March 31, 2023 · filed May 15, 2023
No position changes this quarter.
Loading...